• Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study 

      Moreno-Arribas, José; Bertomeu-González, Vicente; Anguita, Manuel; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (SAGE, 2015-07-30)
      [Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA ...
    • Do physicians correctly calculate thromboembolic risk scores?: a comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores 

      Esteve-Pastor, María Asunción; Marín, Francisco; Bertomeu-Martínez, Vicente; Roldán, Inmaculada; Cequier, Ángel; Badimón, Lina; Muñiz, Javier; Valdés, Mariano; Anguita, Manuel (Wiley, 2016-03-01)
      [Abstract] BACKGROUND: Clinical risk scores, CHADS2 and CHA2 DS2 -VASc scores, are the established tools for assessing stroke risk in patients with atrial fibrillation (AF). AIM: The aim of this study is to assess concordance ...
    • La INR durante los ictus y las hemorragias en pacientes con fibrilación auricular tratados con antagonistas de la vitamina K 

      Anguita-Sánchez, Manuel; Anguita Gámez, María; Bertomeu, Vicente; Ruiz Ortiz, Martín; Cequier, Ángel; Roldán, Inmaculada; Muñiz, Javier; Esteve-Pastor, María Asunción; Vivas Balcones, David; Marín, Francisco; Pérez-Villascastín, Julián (Elsevier, 2020-07)
      [Resumen] Introducción y objetivos. La fibrilación auricular tiene un mal pronóstico asociado fundamentalmente al desarrollo de ictus. A pesar del uso de anticoagulantes, algunos pacientes pueden sufrir ictus y también ...
    • Oral anticoagulation in octogenarians with atrial fibrillation 

      González Saldivar, Hugo; Figueiras-Graillet, Lourdes M.; Anguita, Manuel; Marín, Francisco; Bertomeu, Vicente; Roldán, Inmaculada; Ruiz, Martín; Muñiz, Javier; Martínez-Sellés, Manuel (Elsevier, 2016-08-08)
      [Abstract] Background. Vitamin K antagonists (VKAs) are still largely employed, even in nonvalvular atrial fibrillation (AF). Our aim was to study the clinical profile of octogenarians treated with oral anticoagulation ...
    • Quality of anticoagulation with vitamin K antagonists 

      Bertomeu-González, Vicente; Anguita, Manuel; Moreno-Arribas, José; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (Wiley, 2015-05-11)
      [Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ...